COVID-19 Vaccine Efficacy in Solid Organ Transplant Recipients
COVID-19 Vaccine Efficacy in Solid Organ Transplant Recipients
We’re one step closer to ending the COVID-19 pandemic because of vaccines. And while their efficacy and safety have been established in the general population, recent data in solid organ transplant patients raise concerns. This month’s Journal Club reviews this new data on the SARS-CoV-2 mRNA vaccines in solid organ transplant recipients.
Upon successful completion of this application-based course, pharmacists and pharmacy students should be able to:
1. Compare and contrast the morbidity and mortality associated with COVID-19 in the solid organ transplant population to that of the general population.
2. Explain why patients on immunosuppression have a weakened response to vaccines.
3. Analyze the current evidence on the safety and efficacy of the SARS-CoV-2 mRNA vaccine in solid organ transplant patients.
4. Identify opportunities for future research endeavors evaluating the SARS-CoV-2 mRNA vaccines in solid organ transplant recipients.
5. Develop a recommendation for COVID-19 vaccination in solid organ transplant recipients.
Nicole Alvey, PharmD, BCPS, FAST
Associate Professor of Clinical Sciences
Roosevelt College of Sciences
Clinical Pharmacy Specialist, Transplant
Nicole Alvey does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.
To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read the article cited below and attend the live webinar.
Boyarsky BJ, Werbel WA, Avery RK, et al. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385. PMID: 33720292; PMCID: PMC7961463.
Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients. JAMA. 2021;325(21):2204–2206. doi:10.1001/jama.2021.7489
*CEimpact provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.
This course is included in our Pharmacist Subscription Service. To get more courses like this sent to you every month, sign-up for a CE Subscription Service!
Fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: August 11, 2021
Planned Expiration Date: August 11, 2024
CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.
¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.
Additional information
| Duration | 1h 0m |
|---|---|
| Topic Designator | Disease State/Drug Therapy |
| ACPE | Yes |
| ACPE Topic | 06 Immunizations |
| Role | Pharmacist |
| Media-Type | On-Demand |
| Release Date | 8/11/21 |
| CEUs | 0.1 |
| Rating | 4 |
| ACPE Number | 0107-0000-21-233-H06-P |
